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Abstract
Purpose Epiphora is commonly caused by a relative or complete occlusion in the lacrimal drainage system (LDS), principally 
a nasolacrimal duct obstruction (NLDO). Dacryoscintigraphy (DSG), an extensively assessed imaging technique in diagnos-
ing its abnormalities, can provide only planar images, according to which it needs to be improved. Our aim was to evaluate 
clinical utility of simultaneous DSG and single-photon emission computed tomography/computed tomography (SPECT/CT) 
combined with computed tomographic dacryocystography (CT-DCG) in the evaluation of LDS.
Methods Dynamic imaging with DSG was performed, and tracer radioactivity was detected by a gamma camera. Succes-
sively, SPECT/CT images of the involved region were gained, followed by CT-DCG, during which a contrast medium was 
syringed into the affected LDS, and finally contrast CT scans were obtained again from the same region.
Results Fifty-seven patients, mean age 54.25 (± 18.26) years all with unilateral NLDO and 32 control subjects, all with 
patent LDS, mean age 49.88 (± 18.61) years were evaluated in the study. Delayed outflow of tearing eyes was exposed to 
DSG compared to the fellow and control eyes. The highest value for sensitivity was observed for SPECT/CT, followed by 
CT-DCG and DSG techniques, while combining DSG with SPECT/CT, DSG with CT-DCG, and SPECT/CT with CT-DCG, 
the sensitivity increased to 96.49%, 92.98%, and 94.73%, respectively.
Conclusions Although DSG is a sensitive nuclear medicine method, it only provides useful clinical data when simultaneously 
supplemented with SPECT/CT and CT-DCG trials as they jointly can offer valuable information about the localization of 
an abnormality and verify stenosis or obstruction.
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Introduction
Excessive tearing also known as epiphora, a common com-
plaint in ophthalmological practice, especially in the elderly, 
is due to an imbalance between production and drainage of 
tears. Several etiologies can provoke an excess of tears [1], 
and there are various ways to deal with this condition [2–4]. 
Currently, there is a lack of consensus on managing tearing 
patients, and it is particularly true for diagnostic and differ-
ential diagnostic facilities. Once excluding primary overpro-
duction and reflexive tearing due to secondary overproduc-
tion [5], diverse anatomical malformations of the lacrimal 
drainage system (LDS) permitting tear fluid flow from the 
eye into the nasal cavity can be encountered. Abnormali-
ties can occur on the one part at the entry of the excretory 
system, but more often in the lower part of the LDS, of 
which stenosis or obstruction may be developed by various 
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pathologic reasons, such as congenital malformations, infec-
tions of the eye or nose, traumatic disruption, however, most 
frequently by idiopathic inflammatory obstruction [2]. These 
disorders are clinically characterized by epiphora, purulent 
discharge, and more or less frequently by sterile or infected 
dacryocystitis. An operative solution is indicated in case 
conservative medical therapy fails. Scantiness of diagnostic 
utilizations is unambiguously underpinned by a survey car-
ried out among the members of the American Society of 
Plastic and Reconstructive Surgery revealing that less than 
5% of them applied any pre-operative imaging procedure 
on patients with assumed nasolacrimal duct obstruction 
(NLDO) [6].
In the evaluation of LDS patency, dacryoscintigraphy 
or dacryoscintillography (DSG), a readily available, safe, 
objective, non-invasive, low-radiation-dose nuclear medi-
cine method first introduced by Rossomondo and colleagues 
[7], and modified by numerous authors [8, 9], is expansively 
practiced. Even though it is useable not just in assessing 
LDS patency during diagnostic workup, but also in evaluat-
ing tear outflow following a lacrimal surgery, it allows solely 
planar, two-dimensional images, consequently its sensitivity 
and specificity need to be improved.
To the best of our knowledge, our working group was 
the first to report the simultaneous application of DSG and 
single-photon emission computed tomography/computed 
tomography (SPECT/CT) combined with computer tomo-
graphic dacryocystography (CT-DCG) in the management 
of NLDO [10], and here we are presenting our extended 
outcomes dealing with this procedure as a protocol focusing 
on its effectiveness and clinical utility.
Patients and methods
Study population
Consecutive patients who mentioned epiphora as a major 
complaint were recruited into our prospective, interven-
tional, cross-sectional, case–control study. The diagnosis 
of NLDO was made based on detailed ophthalmic investi-
gations that included slit lamp examination, tear break-up 
time (tBUT), and Schirmer tests, syringing to assess LDS 
patency, as well as otorhinolaryngological endoscopic evalu-
ation of the nasal cavity. An age- and gender-matched popu-
lation for control was also enrolled in the study during the 
same period selected from subjects presenting for routine 
eye examination with minor refractive errors (± 1.0 diopter), 
and no history of any tearing problem. None of the patients 
or controls took any medications that may have influenced 
tear secretion or drainage at the time of the measurements 
and none of them took any eye drops 2 weeks prior to meas-
urements and during study days. Other exclusion criteria 
for both groups were abnormal eyelid position and closure, 
contact lens wearing, history of ocular surgery, presence of 
ocular infection, inflammation of sclera, episcleral layer and 
uvea, trauma of the eye, corneal haze, peripheral or central 
corneal melting.
DSG technique
For the DSG process, a massage was applied on both lac-
rimal sacs to remove any debris out of the upper part of 
tear drainage system. For dynamic investigation of the 
regions of the eye and LDS, one drop (20 µL) of 100 MBq/
mL concentration, effectively 2 MBq activity of 99mTc-
sodium pertechnetate as a radioactive tracer with a half-life 
for gamma emission of 6.0058 h in a saline solution, was 
administered per eye with a micropipette without using any 
local anesthetic eye drop. Special attention was taken to 
prevent any contamination of the patients’ face with radi-
olabeled tear, which could interfere with the interpretation 
of the study. After administration, patients and members of 
the control group were placed in a sitting position in front 
of a planar camera for imaging. To ensure patients’ immo-
bilization, their head was secured by a gum strip to obtain 
optimal imaging. Measurements were performed according 
to a dynamic data acquisition protocol using 10 s/frame for 
15 min (90 × 10 s), which resulted in summed DSG images. 
Tracer radioactivity as it passes along the lacrimal pathway 
was detected by a gamma camera (Mediso Nucline TH/22, 
Budapest, Hungary) with a low-energy high-resolution col-
limator using a 128 × 128 matrix. After investigations, both 
eyes were flushed with saline to help clear the remaining 
radioactivity. Data were also appraised in special regions 
of interest (ROIs) separately, and consecutive time activity 
curves were created (Figs. 1, 2).  Tmax and  T½ (tear clearance) 
values were calculated based on the activity curves.  Tmax 
is the time point when the time activity curve reaches the 
maximum value, while  T1/2 time is the point on the descend-
ing part of the curve, when the time activity curve reaches 
the moiety of  Tmax activity value. 
All DSG results were evaluated by two experienced 
observers (SB and KK), who were familiar with DSG and 
unaware of other clinical data, and the final evaluation was 
made by consensus. Controls were only tested by DSG due 
to ethical reasons.
SPECT/CT and CT‑DCG examinations in patients
Followed by DSG, a SPECT/CT examination occurred in 
supine position. During the SPECT investigation, the pro-
tocol was as follows: 32 frames per detector head, each 
with duration of 20 s, 360°, and acquisition matrix size 
of 128 × 128. The 2D OSEM (ordered subset expectation 
maximization) reconstruction method was used. A smooth 
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filter and a Butterworth filter were applied with the follow-
ing parameters: cutoff to zero: 70; gain: 0; cutoff frequency: 
0.32; order: 25; no post-filters were implemented.
The CT acquisition was conducted immediately after the 
SPECT acquisition along these lines: image matrix size: 
128 × 128, tube voltage 120 kV, and 50 mAs (AnyScan 
FLEX SC, Budapest, Hungary). Then followed by locally 
anesthetizing the conjunctival sac by administering 2% 
xylocaine eye drops, 0.5–1 mL of contrast material (iover-
sol, Optiray 350, Guerbet, France) was syringed into the 
affected LDS by a trained ophthalmologist (A K-B); sequen-
tially contrast CT scans for the same coordinate frame also 
applying the previous protocol were acquired. Data were 
obtained as axial images and then reconstructed into 2D and 
3D coronal and parasagittal planes along the major axis of 
the LDS (Fig. 3).
The study protocol was approved by the local ethics 
committee (Regional and Institutional Research Ethi-
cal Committee [DE RKEB/IKEB 4779-2017] together 
with the National Institute of Pharmacy and Nutrition 
[OGYEI/37752/2017]) and was in full compliance with 
good clinical practices (GCP) guidelines of the Euro-
pean Union, and the Declaration of Helsinki (1996). By 
signing a written informed consent, all patients and con-
trols agreed to have the study results regarding any side 
effects as well as possible risks and benefits of the study 
published.
Statistical analyses
Both eyes of the patients and one randomly selected eye 
from each control were selected for the statistical analyses. 
Tracer disappearance times were expressed in seconds as 
mean values and standard deviations (± SD), whereas cat-
egorical variables were expressed as frequencies and their 
percentages. Distribution of data was checked using the 
Kolmogorov–Smirnov test. A non-parametric (Wilcoxon) 
test was used to compare groups. Correlation coefficients 
between variables were calculated with Spearman’s 
method. Kappa test was used to compare inter-rater reli-
ability between different methods. p values less than 0.05 
were considered statistically significant. For the statistical 
analysis, IBM SPSS 24 statistical software (IBM Corp., 
Armonk, New York, USA) was used.
Fig. 1  DSG result of a patient suffering from left side NLDO: the 
right side is patent, while a significant obstruction on the left side 
stops tear outflow from the region of eye toward the lacrimal path-
way. DSG dacryoscintigraphy, NLDO nasolacrimal duct obstruction, 
left region 1 region of the left eye, right region 1 region of the right 
eye, left region 2 region of the left nasolacrimal duct, right region 2 
region of the right nasolacrimal duct
 Annals of Nuclear Medicine
1 3
Fig. 2  DSG result of a control subject: both sides are patent, for 
this reason normal scintigrams can be depicted for both sides. DSG 
dacryoscintigraphy, left region 1 region of the left eye, right region 
1 region of the right eye, left region 2 region of the left nasolacrimal 
duct, right region 2 region of the right nasolacrimal duct
Fig. 3  SPECT/CT result of the 
patient represented in Fig. 1 
on coronal and sagittal images: 
activity of 99mTc-sodium 
pertechnetate can be detected on 
the right region of the nasolacri-
mal duct, but there is no outflow 








Fifty-seven consecutive patients, 45 women and 12 men, age 
54.25 (± 18.26) years, and 32 control subjects, 24 women 
and 8 men, age 49.88 (± 18.61) years were examined. All 
patients were referred with unilateral watering eye and were 
measured followed by a negative syringing. There was no 
significant difference between demographic data of patients 
and controls.
DSG, SPECT/CT and CT‑DCG outcomes
Concerning DSG outcomes, the difference calculated 
between mean  T1/2 values in the eye region both for tearing, 
fellow, and control eyes and mean  Tmax values for tearing 
and fellow eyes was significant. Interestingly, in the NLD 
region, mean  Tmax value was the most decreased for the tear-
ing eye with a higher value for the fellow eye, and the high-
est for the control eye. The difference was statistically also 
significant. Data are presented in Table 1.
In general, the association between  Tmax values of the 
tearing and the fellow eyes was weak. Correlation coeffi-
cient was significant between  Tmax values of the LDS regions 
for the tearing and the fellow eye; the results are shown in 
Fig. 4. Concerning sensitivity, SPECT/CT proved to be 
the most sensitive method (87.72%), followed by CT-DCG 
(78.95%), and DSG (68.42%). While combining the tech-
niques, the sensitivity values were as follows: DSG with 
SPECT/CT: 96.49%, DSG with CT-DCG: 92.98%, and 
SPECT/CT with CT-DCG: 94.73%, respectively. Speci-
ficity of DSG was found to be higher when compared to 
SPECT/CT technique. Data are represented in Table 2. The 
kappa coefficient used to test inter-rater reliability was 0.315 
between CT-DCG and SPECT/CT with the difference being 
statistically significant (see Table 3), while it was − 0.020 
between DSG and SPECT/CT, and 0.019 between DSG and 
CT-DCG with no statistical significance.
Discussion
The adequate volume and the appropriate, well-balanced 
composition of tears are indispensable for maintaining ocu-
lar surface health. Precorneal tear film has several essential 
functions including protecting the cornea from drying, con-
tributing to the refractive power of the eye, or defending the 
structures inside the eye against infections. These roles are 
regulated by the lacrimal functional unit (LFU) that con-
sists of the tear production system, i.e., the main and acces-
sory lacrimal glands, the interconnecting innervations, fluid 
flow, tear evaporation, and last but not least the tear outflow 
Table 1  Maximum  (Tmax) and half-life  (T1/2) tracer and radioactive tracer disappearance time values in the region of eyes and NLD in the tear-
ing, fellow, and control eyes
Bold values indicate significant differences. Though representing significant differences, values in italics can only be taken into account in a 
restricted degree as the radioactive tracer can slightly reach NLDs in tearing eyes because of stenosis or obstruction
n number of patients/controls, NLD nasolacrimal duct, p p value










tearing eye  
vs. fellow eye
p
tearing eye  
vs. control eye
p
fellow eye  
vs. control eye
Eye  Tmax 45 ± 56 48 ± 90 37 ± 150 0.794 < 0.001 < 0.001
Eye  T1/2 1579 ± 427 1274 ± 537 1008 ± 580 < 0.001 < 0.001 0.004
NLD  Tmax 418 ± 316 564 ± 485 651 ± 330 0.011 0.003 0.060
NLD  T1/2 1212 ± 592 1100 ± 648 1088 ± 579 0.470 0.255 0.550
Fig. 4  Correlation between maximum tracer disappearance time 
 (Tmax) values of tearing and fellow eyes. p p value, R correlation coef-
ficient
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through the LDS. Assessment of the LFU is crucial not only 
in consideration of diagnosing lacrimal apparatus disorders, 
but also in evaluating ocular surface processes and effective-
ness of therapies in these lesions in follow-up periods. Both 
quantitative and qualitative alterations can occur related to 
LFU. Concerning the previous ones, epiphora is one of the 
most common ophthalmic symptoms. Its etiology can be 
broadly categorized into tear overproduction and inadequate 
drainage, and the latter can be put down to either anatomical 
or functional obstructions. The previous one, with a preva-
lence of 31.8–48.7%, can develop a blockage at any point 
along the LDS [11–13], while the latter one is termed for 
delayed or blocked tear outflow in the absence of mechanical 
obstruction in the LDS, and can be determined, from out-
ermost to innermost, by dysfunction of the lacrimal pump, 
abnormal localization or blockage of the orifice, i.e., lacri-
mal puncta, and stenosis of the LDS [14]. To differentiate 
between stenosis and obstruction is indispensable since the 
former one can be treated by balloon catheter dilation or 
intubation, but the latter one, of which NLDO is the most 
frequent form being 4–5 times more prevalent in females 
[15] than in males, requires invasive surgical interventions 
[16, 17].
There are only scant objective techniques in the visuali-
zation and imaging of the LDS, and thus its abnormalities 
are mostly diagnosed via anamnestic data and a few clinical 
tests, which include tBUT, Schirmer, and Jones dye tests, 
syringing, and nasolacrimal probing [18, 19]. Among classic 
imaging modalities, X-ray, DCG, CT, or magnetic resonance 
imaging (MRI) can effectively assess obstruction; however, 
their success is much less in the evaluation of stenosis. On 
the contrary, DSG, being an objective and precise technique, 
provides real and accurate data about functional NLDO and 
supplies more detailed outcomes if partial obstruction occurs 
[20]. Hanna and co-workers analyzed the DSG results of 
83 eyes of 67 patients, and though 55 LDSs were found 
to be patent by syringing, only 36 (65%) were found to be 
impaired by DSG [21]. The relevance of DSG is also sup-
ported by the fact that a great correspondence was reported 
between clinical assessment of epiphora and DSG in case of 
patent but non-functioning lacrimal systems [22].
DSG method is even capable of distinguishing localiza-
tions of LDS obstructions, and accordingly positive scinti-
grams were subdivided into prelacrimal sac, lacrimal sac/
duct junction, and duct obstructions, and diverse incidences 
were described by different authors [20, 23–25]. Moreover, 
quantitative DSG, a measurement performed routinely in 
some departments [26], permits to quantify tear clearance 
rate and, based on time, activity curves can evaluate LFU 
globally [27].
It can be concluded that for the evaluation of the LFU 
under action, DSG is the most readily available, non-inva-
sive method; however, it has some disadvantages. On the 
one hand, they are due to the fact that the lumen diameter of 
LDS is not constant but influenced by several drugs [28–30]. 
On the other hand, quantification can be elusive since it can 
provide little extra information if complete NLDO occurs. 
Moreover, to find an appropriate standardized point of ref-
erence related to an obstructed LDS comes up against dif-
ficulties since although the fellow, unaffected eye could be 
Table 2  Sensitivity and specificity of DSG, SPECT/CT, and CT-DCG procedures in the tearing, fellow, and control eyes
DSG dacryoscintigraphy, SPECT/CT single-photon emission computed tomography/computed tomography, CT-DCG computed tomographic 







Sensitivity (%)  
(95% CI)
Specificity (%) (95% CI)
Fellow eye Control eye
DSG positive 39 (68.42%) 23 (40.35%) 8 (25%) 68.42 (54.65–79.76) 59.65 (45.82–72.25) 75.0 (56.26–87.94)
SPECT/CT positive 50 (87.72%) 36 (63.16%) – 87.72 (75.72–94.58) 36.84 (24.85–50.76) –
CT-DCG positive 45 (78.95%) – – 78.95 (65.82–88.26) – –
DSG or SPECT/CT 
positive
55 (96.49%) 41 (71.93%) – 96.49 (86.84–99.48) 28.07 (17.47–41.75) –
DSG or CT-DCG 
positive
53 (92.98%) – – 92.98 (82.15–97.76) – –
SPECT/CT or CT-
DCG positive
54 (94.73%) – – 94.73 (84.55–98.63) – –
Table 3  Comparison of contrast CT and SPECT/CT cases based on 
inter-rater reliability
SPECT/CT single-photon emission computed tomography/computed 
tomography, CT-DCG computed tomographic dacryocystography, n 
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asymptomatic, stenosis or subclinical obstruction is often 
seen; as a consequence, it cannot always be used as a con-
trol [31]. In our study, the observation that fellow eyes  Tmax 
parameter was the highest and  T1/2 quantity was higher com-
pared to control eyes also supports this observation. Our 
theory about the reason why  Tmax value was the highest and 
 T1/2 parameter was also increased for the region of nasol-
acrimal duct in case of control eyes is that 99mTc-sodium 
pertechnetate can attach considerably to the mucosa or it is 
even absorbed by mucous membranes that cover the inner 
surface of the nasolacrimal drainage system. Our DSG data 
are in accordance with the literature [32].
Based on our outcomes, 8 out of the 32 control eyes DSG 
results were positive that were otherwise declared as clini-
cally negative. As previously, several studies have found 
weak or no correlations between objective signs and sub-
jective symptoms of dry eye disease (DED) [33, 34], further 
investigations are needed to verify possible LDS abnormali-
ties or DED in these control eyes.
LDS can be involved even in a high-dose radioactive 
iodine (RAI) therapy that is applied against thyroid disor-
ders. RAI is excreted in tears and actively accumulated in 
LDS and subsequently lacrimal gland impairment [35] as 
well as epiphora can develop since the low, but concentrated 
level of RAI induces inflammation that stimulates stenosis 
or obstruction [36]. Investigating RAI administration in a 
high number of patients, a cutoff level of 150 mCi was deter-
mined since toxicity and consecutive inflammation that leads 
to obstruction of LDS occurred in patients who received 
RAI doses above this level [37].
Although the application of a pinhole collimator cam-
era during DSG [38] can be beneficial, it could be difficult 
to map the region of the eye with it because of the design 
of the collimator, since patients cannot fix their heads and 
not move. In our department, DSG using a pinhole colli-
mator could have been performed only with patients in a 
lying position. Nevertheless, it is worth examining patients 
in near physiological conditions, namely in standing or sit-
ting position as their complaints also occur when sitting or 
standing up. For cameras equipped with LEHR (low-energy 
high-resolution) collimators, patients can fix their chin and 
forehead in a special holder close enough to the detector, and 
also they are able to embrace the detector, so that potential 
movements will be rather negligible.
Thus, there is a general agreement across authors that 
because of some disadvantages DSG can provide only addi-
tional data to clinical evaluation, and nowadays it is mostly 
regarded as a supplementary method to evaluate tearing 
features which then may help specialists to select the most 
appropriate type of treatment. As a result of these con-
siderations, other non-invasive or less invasive diagnostic 
techniques should be involved in the medical checkup of 
epiphoretic patients [39]. An efficient modality in diagnos-
ing deviations of the LDS is DCG, and combining the two 
techniques sensitivity can be increased to 98% [23]. The 
discrepancy between the two techniques is mostly explained 
by the fact that during DCG a high-pressure contrast injec-
tion of fluid is administered into the LDS that can come 
through incomplete obstruction sites, while DSG imitates 
physiological tear flow, which makes it eligible to investi-
gate functional epiphora insomuch as it is recommended as 
a first-line investigation in these cases [20]. Nevertheless, 
in the management of epiphoretic patients, DCG cannot be 
passed over since it is deemed to be the criterion standard 
for diagnostic imaging of LDS obstruction [40].
To the best of our knowledge, the first application of 
SPECT/CT for visualization of the LDS was used by Saka-
hara and et al. as early as 2007, who investigated the uptake 
of 131I in the LDS after radioiodine therapy [36]. Afterward 
simultaneous use of DSG and SPECT/CT combined with 
DCG was described by our team, where we identified the 
discrepancy between the passive DSG and actively executed 
DCG [10]. CT application was chosen as no other imaging 
facility can offer as distinct an anatomic detail of the bony 
LDS as CT. Anyway, CT-DCG can resolve pre-operative 
characterization of a possible occlusion by improving pla-
nar imaging of DSG, and this localization is required for 
a correct treatment planning. In our present survey, the 
kappa value measuring inter-rater reliability between dif-
ferent methods was found to be 0.315 between CT-DCG 
and SPECT/CT; and as the difference was statistically sig-
nificant, it means that these two independent imaging tech-
niques can lead to a matching decision.
Conclusions
There are scant diagnostic conceptualizations and no stand-
ardized examinations for LDS abnormalities; consequently, 
evaluation of tearing patients is generally based on history, 
external ophthalmic physical examination, and straightfor-
ward office lacrimal tests enhanced when inevitable by nasal 
examination.
DSG is a widely employed effective modality in diagnos-
ing abnormalities of the LDS which can provide relatively 
objective data on LDS impairments; however, when using 
a planar camera for imaging, this facility should be poten-
tiated. Furthermore, surgical indication can be established 
only based on supported images, and additionally, precise 
localization of the obstruction can be merely determined 
by detailed imaging. The simultaneous application of DSG, 
SPECT/CT combined with CT-DCG can provide careful 
final results with high sensitivity.
The main advantage of the study is the measured control 
eyes involved in DSG since most of the surveys that deal 
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with DSG of tearing patients quantify only the affected eyes. 
Another advantage is the wide range of imaging techniques 
that were compared. However, the main limitations of the 
study could be the relatively small sample size and lack of 
SPECT/CT and DCG modalities for control eyes due to ethi-
cal reasons.
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